Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intranasal Insulin on POCD and POD
NCT03415061Unknown
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) comparing Intranasal Insulin with Placebo (2 arms). Primary endpoints: Confusion Assessment Method for the ICU, Rey Auditory Verbal Learning Test up to 12 month and 1 more. Status: unknown.
02
Drugs
regular human insulin
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT03415061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415061.